Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 7/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19395363 | 0.96 | EPHX1 (0.41) | ALDH1A1CA1CA2ATMACHE | |
| SCHEMBL19395411 | 0.94 | EPHX1 (0.44) | ACHEEPHX1TSHRCES2 | |
| SCHEMBL19395332 | 0.94 | EPHX1 (0.44) | ACHEEPHX1TSHRCES2 | |
| SCHEMBL19395362 | 0.89 | ALDH1A1 (0.33) | ALDH1A1CA1CA2ATM | |
| SCHEMBL19395351 | 0.81 | ALDH1A1 (0.45) | ALDH1A1CA1CA2ATMACHE | |
| SCHEMBL19395340 | 0.80 | ALDH1A1 (0.43) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL19395361 | 0.79 | — | — | |
| SCHEMBL19395412 | 0.78 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL2379692 | 0.72 | ALDH1A1 (0.35) | ALDH1A1CA1CA2ATMTSHR | |
| SCHEMBL19395418 | 0.72 | ALDH1A1 (0.50) | ALDH1A1ATMACHEEPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275311-A1 | NON-AQUEOUS LIQUID ELECTROLYTE, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHORUS COMPOUND USED THEREIN | UBE INDUSTRIES, LTD. (JP) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275311-A1 | NON-AQUEOUS LIQUID ELECTROLYTE, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHORUS COMPOUND USED THEREIN | SCN10A, CACNA2D4, P2RY10 | ALDH1A1 3034/4885CA1 467/4885CA2 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.